Join TriSalus Life Sciences for a virtual key opinion leader (KOL) event featuring Juan C. Camacho, MD (Florida State University), who will join company management to discuss the unmet need and current treatment landscape for symptomatic thyroid disease.

The event will provide an overview of the TriNav Infusion System and its Pressure-Enabled Delivery for Thyroid Artery Embolization (PED-TAE) approach. PED-TAE targets the inferior thyroid arteries and aims to reduce gland size and alleviate symptoms in patients who are not candidates for surgery or conventional therapies.

A question and answer session will follow the formal presentations.